
NightHawk Biosciences, Inc.
AMEX:NHWK
Overview | Financials
Company Name | NightHawk Biosciences, Inc. |
Symbol | NHWK |
Currency | USD |
Price | 0.442 |
Market Cap | 11,517,767 |
Dividend Yield | 0% |
52-week-range | 0.36 - 1.52 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jeffrey Alan Wolf J.D. |
Website | https://www.nighthawkbio.com |
An error occurred while fetching data.
About NightHawk Biosciences, Inc.
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD